The Association For The Advancement Of Human Longevity Launches New Website

Livetobe1000.com Will Ensure That Radical Life Extension Technologies are Readily Accessible to Public. End Quote

(1888PressRelease) September 28, 2012 - Delaware, 20 - The Association for the Advancement of Human Longevity (AAHL) launched livetobe1000.com, which will advocate for public access to new life extending technologies.

"We human beings are now capable of taking control of our own evolution through technology," says Company Founder and Author Mr. Daman Burrage, "considering our current economical and geopolitical configurations, one cannot assume these technologies will be readily available to everyone." Mr. Burrage added.

The Livetobe1000 website is a platform for AAHL to inform the public of Life Science Technology breakthroughs with its online database and awareness campaigns, to aggressively fund new R&D projects through Government Grants as well as an Regulation D Offering, and to guarantee the rights of private citizens to have access to future Life Enhancing Technologies through its online petitions to the U.S. Government.

"It is only fair for everyone to have access to what is coming. Unfortunately, life is not fair. Useful technologies are often not utilized, in favor of more expensive (and profitable) ones." says Israel Rothman, The number one "Internet advertising consultant" in the world according to Google organic search and Founding member of http://upLog.org.

Other features that will be included in the Livetobe1000.com site include:

Link to current news about Biogenetics, Nanotechnology, Artificial Intelligence, and Emerging Technologies
The Livetobe1000 Blog covering topics such as: Transhumanism, Societies Transition Into the Singularity, and the Impacts on Humanity of an Post Human Era
An open forum, where anyone can voice their opinion concerning the most controversial discussions regarding Transhumanism
AAHL Membership and its benefits, for example, access to research data, funding requests for new projects, and clinical trial watch lists.

###

space

Other Related Press Releases